723 related articles for article (PubMed ID: 27176479)
1. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y
BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479
[TBL] [Abstract][Full Text] [Related]
2. MRI-based comparative study of different mild cognitive impairment subtypes: protocol for an observational case-control study.
Yu Y; Zhao W; Li S; Yin C
BMJ Open; 2017 Mar; 7(3):e013432. PubMed ID: 28274963
[TBL] [Abstract][Full Text] [Related]
3. Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort.
Dufouil C; Dubois B; Vellas B; Pasquier F; Blanc F; Hugon J; Hanon O; Dartigues JF; Harston S; Gabelle A; Ceccaldi M; Beauchet O; Krolak-Salmon P; David R; Rouaud O; Godefroy O; Belin C; Rouch I; Auguste N; Wallon D; Benetos A; Pariente J; Paccalin M; Moreaud O; Hommet C; Sellal F; Boutoleau-Bretonniére C; Jalenques I; Gentric A; Vandel P; Azouani C; Fillon L; Fischer C; Savarieau H; Operto G; Bertin H; Chupin M; Bouteloup V; Habert MO; Mangin JF; Chêne G;
Alzheimers Res Ther; 2017 Aug; 9(1):67. PubMed ID: 28851447
[TBL] [Abstract][Full Text] [Related]
4. [Effect of apolipoprotein E genotype on magnetic resonance spectrum in amnestic mild cognitive impairment and Alzheimer's disease patients].
Zhu XQ; Zhou X; Zhao W; Zhang YM; Liu FJ; Cao J; Sun ZW
Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1156-1161. PubMed ID: 31006219
[No Abstract] [Full Text] [Related]
5. Association between plasma exosome neurogranin and brain structure in patients with Alzheimer's disease: a protocol study.
He M; Sun L; Cao W; Yin C; Sun W; Liu P; Tan L; Xu Z; Zhao W
BMJ Open; 2020 Aug; 10(8):e036990. PubMed ID: 32801201
[TBL] [Abstract][Full Text] [Related]
6. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
7. Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.
Yu P; Dean RA; Hall SD; Qi Y; Sethuraman G; Willis BA; Siemers ER; Martenyi F; Tauscher JT; Schwarz AJ
J Alzheimers Dis; 2012; 32(2):373-85. PubMed ID: 22796873
[TBL] [Abstract][Full Text] [Related]
8. Effect of APOE ε4 genotype on amyloid-β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment.
Li W; Li R; Yan S; Zhao Z; Shan Y; Qi Z; Lu J;
Eur J Neurol; 2023 Mar; 30(3):587-596. PubMed ID: 36448771
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric MRI for the improved diagnostic accuracy of Alzheimer's disease and mild cognitive impairment: Research protocol of a case-control study design.
Piersson AD; Ibrahim B; Suppiah S; Mohamad M; Hassan HA; Omar NF; Ibrahim MI; Yusoff AN; Ibrahim N; Saripan MI; Razali RM
PLoS One; 2021; 16(9):e0252883. PubMed ID: 34547018
[TBL] [Abstract][Full Text] [Related]
10. Modulation on brain gray matter activity and white matter integrity by APOE ε4 risk gene in cognitively intact elderly: A multimodal neuroimaging study.
Cai S; Jiang Y; Wang Y; Wu X; Ren J; Lee MS; Lee S; Huang L
Behav Brain Res; 2017 Mar; 322(Pt A):100-109. PubMed ID: 28108320
[TBL] [Abstract][Full Text] [Related]
11.
Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
[TBL] [Abstract][Full Text] [Related]
12. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
13. Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment.
Cho H; Kim YE; Chae W; Kim KW; Kim JW; Kim HJ; Na DL; Ki CS; Seo SW
Sci Rep; 2020 Aug; 10(1):13365. PubMed ID: 32770103
[TBL] [Abstract][Full Text] [Related]
14. Multimodal MRI for early diabetic mild cognitive impairment: study protocol of a prospective diagnostic trial.
Yu Y; Sun Q; Yan LF; Hu YC; Nan HY; Yang Y; Liu ZC; Wang W; Cui GB
BMC Med Imaging; 2016 Aug; 16(1):50. PubMed ID: 27552827
[TBL] [Abstract][Full Text] [Related]
15. Motor timing intraindividual variability in amnestic mild cognitive impairment and cognitively intact elders at genetic risk for Alzheimer's disease.
Kay CD; Seidenberg M; Durgerian S; Nielson KA; Smith JC; Woodard JL; Rao SM
J Clin Exp Neuropsychol; 2017 Nov; 39(9):866-875. PubMed ID: 28052734
[TBL] [Abstract][Full Text] [Related]
16. Conversion from MCI to AD in patients with the APOE ε4 genotype: Prediction by plasma HCY and serum BDNF.
Zheng L; Kong X; Cui Y; Wei Y; Zhang J; Wei W
Neurosci Lett; 2016 Jul; 626():19-24. PubMed ID: 27180036
[TBL] [Abstract][Full Text] [Related]
17. Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE ɛ4) alleles for the diagnosis of mild cognitive impairment and Alzheimer's disease.
Niu X; Wang Y; Zhang X; Wang Y; Shao W; Chen L; Yang Z; Peng D
Neurol Sci; 2024 Feb; 45(2):547-556. PubMed ID: 37673807
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E ε4 Specifically Modulates the Hippocampus Functional Connectivity Network in Patients With Amnestic Mild Cognitive Impairment.
Zhu L; Shu H; Liu D; Guo Q; Wang Z; Zhang Z
Front Aging Neurosci; 2018; 10():289. PubMed ID: 30319395
[TBL] [Abstract][Full Text] [Related]
19. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
[TBL] [Abstract][Full Text] [Related]
20. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
